In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.

Cigna's Evernorth Health Services said on Wednesday its actions will enhance transparency about the company's negotiations.

As Lina Khan, chair of the Federal Trade Commission, ends her tenure this week the FTC posted a second report in six months ...

The new document focuses on the influence of PBMs over the market for specialty generic drugs for illnesses like cancer, ...

Tucked into the bipartisan budget deal that President-elect Donald Trump’s allies torpedoed earlier this month was a rare and significant attempt to reform the mechanics of America’s drug ...

The Arkansas Pharmacists Association is calling for public and legislative support for stronger regulation of Pharmacy ...

The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.